`

Tagged: White Paper

BBCR is pleased to present the following White Paper – Surrogate Endpoints for an Accelerated Orphan Drug Approval

November 29th, 2021 | White Paper

Rare Diseases are conditions that affect less than 200,000 people in the U.S. However, over 7,000 Rare Diseases affect more than 400,000,000 people worldwide, including ~25 million in the U.S. and ~30 million in Europe (1). In recent years, the number of orphan drugs approved has increased significantly. However, developing and marketing orphan drugs remains […]

Pin It on Pinterest